| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/24/2010 | EP1007084B1 Immunogenic lhrh compositions and methods relating thereto |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN101653594A Somatostatin-dopamine chimeric analogs |
| 02/24/2010 | CN101653424A 高药物载荷片剂 High drug load tablets |
| 02/24/2010 | CN101653354A Noninvasive measurements of chemical substances |
| 02/24/2010 | CN100591762C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/24/2010 | CN100591760C Process for producing cytotoxic lymphocyte |
| 02/24/2010 | CN100591691C Anti-tumour compound |
| 02/24/2010 | CN100591689C Solid salts of benzazepine compounds and its uses in preparing pharmaceutical compound containing them |
| 02/24/2010 | CN100591355C Compositions for treating hyperproliferative conditions and its pharmaceutical uses |
| 02/24/2010 | CN100591331C Combination chemotherapy compositions |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7668659 Diagnosis and classification of multiple myeloma |
| 02/23/2010 | US7667052 Bioactive substance |
| 02/23/2010 | US7667036 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/23/2010 | US7667027 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7667013 Gene encoding a guanine nucleotide exchange factor and the gene product thereof |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667007 αvβ3-specific antibodies |
| 02/23/2010 | US7667002 Peptides and proteins for early liver development and antibodies thereto |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666998 Cell growth inhibitor containing anti-PepT antibody |
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666985 HLA-A24-restricted cancer antigen peptides |
| 02/23/2010 | US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants |
| 02/23/2010 | US7666905 Compositions comprising hepoxilin analogs and their use in the treatment of cancer |
| 02/23/2010 | US7666897 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666874 hypereosinophilic syndrome with resistance to imatinib |
| 02/23/2010 | US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative |
| 02/23/2010 | US7666862 2,4-Diphenyl-1-(hexamethylenimin-4-ylaminocarbonyl)dihydropyrrole derivatives that are useful for treating cancer |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666639 Plant deoxyribonucleoside kinase enzymes and their use |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666604 Modified soluble T cell receptor |
| 02/23/2010 | US7666581 Complexing antigenic proteins/peptides; membrane proteins; tumor associated antigens |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666426 Method for immune response eliciting in a mammal |
| 02/23/2010 | US7666425 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2442974C Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2403566C Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3 |
| 02/18/2010 | WO2010019954A2 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 02/18/2010 | WO2010019899A1 cMET INHIBITORS |
| 02/18/2010 | WO2010019864A2 Ficus extracts having angiogenesis inhibiting activity and methods of isolating and using the same |
| 02/18/2010 | WO2010019775A2 Methods of treating ras driven cancer in a subject |
| 02/18/2010 | WO2010019701A2 Diaryl urea derivatives |
| 02/18/2010 | WO2010019659A1 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use |
| 02/18/2010 | WO2010019549A2 Indoprofen derivatives for promoting bone growth |
| 02/18/2010 | WO2010019473A1 Aurora kinase modulators and methods of use |
| 02/18/2010 | WO2010019276A2 Method and formulation for treating adverse biological conditions |
| 02/18/2010 | WO2010019257A2 Prodrug activation in cancer cells using molecular switches |
| 02/18/2010 | WO2010019233A1 Multi-arm polymeric alkanoate conjugates |
| 02/18/2010 | WO2010019210A2 Halofuginone analogs for inhibition of trna synthetases and uses thereof |
| 02/18/2010 | WO2010019120A1 S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma |
| 02/18/2010 | WO2010019103A1 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 02/18/2010 | WO2010018846A1 Drug containing antibody composition specifically binding to ganglioside gm2 |
| 02/18/2010 | WO2010018764A1 Anti-angiogenic agent, and screening method and screening kit for same |
| 02/18/2010 | WO2010018481A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
| 02/18/2010 | WO2010018327A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
| 02/18/2010 | WO2010018268A1 Novel (rs)-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-il)-7h or 9h-purines having antitumour activity |
| 02/18/2010 | WO2010018223A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 02/18/2010 | WO2010018217A2 Organic compounds for wound healing |
| 02/18/2010 | WO2010018207A1 Endoglin peptides, vaccines and methods for preparing the same |
| 02/18/2010 | WO2010018182A1 Peptidic and peptidomimetic compounds for regulating autophagy |
| 02/18/2010 | WO2010018133A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010018132A1 Compounds |
| 02/18/2010 | WO2010018131A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010018130A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010017870A1 Bicyclic triazole derivatives for treating tumors |
| 02/18/2010 | WO2010017827A1 6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases |
| 02/18/2010 | WO2010017743A1 The injectable sustained-release formulation of lhrh antagonists and the preparation thereof |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2010017587A1 Novel protease inhibitors |
| 02/18/2010 | WO2009155121A3 Inhibitors of pi3 kinase |
| 02/18/2010 | WO2009150381A3 Azacarboline derivatives, preparation thereof, and therapeutic use thereof as kinase inhibitors |
| 02/18/2010 | WO2009146099A3 Contrast agents, methods for preparing contrast agents, and methods of imaging |
| 02/18/2010 | WO2009144738A4 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 02/18/2010 | WO2009139972A3 Site specific fluorescence marking and contrast marker for same |
| 02/18/2010 | WO2009139891A3 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof |
| 02/18/2010 | WO2009135000A3 Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-117199 and analogs |
| 02/18/2010 | WO2009134962A3 Claudin-4 binding peptides, compositions and methods of use |
| 02/18/2010 | WO2009129260A3 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 02/18/2010 | WO2009126705A3 Induction of tumor hypoxia for cancer therapy |